| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-14 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |